Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase

Oligonucleotides

Volumn 18, Issue 2, 2008, Pages 133-144

  DeStefano, Jeffrey J ^a   Nair, Gauri R ^a  

^a Bldg 142   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; NUCLEOTIDE DERIVATIVE; PHOSPHOTHIOATE; PRIMER DNA; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SINGLE STRANDED DNA;

ARTICLE; BASE PAIRING; BINDING AFFINITY; COMBINATORIAL CHEMISTRY; DNA BINDING; DNA FLANKING REGION; DNA MODIFICATION; DNA SEQUENCE; DNA TEMPLATE; ENZYME INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; GUANINE; HIV REVERSE TRANSCRIPTASE; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PHOSPHORYLATION; REVERSE TRANSCRIPTASE INHIBITORS; RNA; SELEX APTAMER TECHNIQUE; TEMPLATES, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 47649122592     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0103     Document Type: Article

References (56)

1. ARNOLD, E., JACOBO-MOLINA, A., NANNI, R.G., WILLIAMS, R.L., LU, X., DING, J., CLARK, A.D., JR., ZHANG, A., FERRIS, A.L., CLARK, P., ET AL. (1992). Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature 357, 85-89.
2. BRODY, E.N., and GOLD, L. (2000). Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 74, 5-13.
3. CHEN, H., and GOLD, L. (1994). Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity. Biochemistry 33, 8746-8756.
4. COTE, M.L., PFLOMM, M., and GEORGIADIS, M.M. (2003). Staying straight with A-tracts: a DNA analog of the HIV-1 polypurine tract. J. Mol. Biol. 330, 57-74.
5. DASH, C., FISHER, T.S., PRASAD, V.R., and LE GRICE, S.F. (2006). Examining interactions of HIV-1 reverse transcriptase with single-stranded template nucleotides by nucleoside analog interference. J. Biol. Chem. 281, 27873-27881.
6. DEISINGH, A.K. (2006). Aptamer-based biosensors: biomedical applications. Handb. Exp. Pharmacol. 341-357.
7. DESTEFANO, J.J., and CRISTOFARO, J.V. (2006). Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity. Nucleic Acids Res. 34, 130-139.
8. DESTEFANO, J.J., BUISER, R.G., MALLABER, L.M., BAMBARA, R.A., and FAY, P.J. (1991). Human immunodeficiency virus reverse transcriptase displays a partially processive 3′ to 5′ endonuclease activity. J. Biol. Chem. 266, 24295-24301.
9. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
10. FERGUSON, M.R., ROJO, D.R., SOMASUNDERAM, A., THIVIYANATHAN, V., RIDLEY, B.D., YANG, X., and GORENSTEIN, D.G. (2006). Delivery of double-stranded DNA thioaptamers into HIV-1 infected cells for antiviral activity. Biochem. Biophys. Res. Commun. 344, 792-797.
11. FISHER, T.S., JOSHI, P., and PRASAD, V.R. (2002). Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication. J. Virol. 76, 4068-4072.
12. FU, T.B., and TAYLOR, J. (1992). When retroviral reverse transcriptases reach the end of their RNA templates. J. Virol. 66, 4271-4278.
13. FURFINE, E.S., and REARDON, J.E. (1991). Reverse transcriptase RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 266, 406-412.
14. GOLD, L. (1995). The SELEX process: a surprising source of therapeutic and diagnostic compounds. Harvey Lect. 91, 47-57.
15. GOPALAKRISHNAN, V., PELISKA, J.A., and BENKOVIC, S.J. (1992). Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl. Acad. Sci. USA 89, 10763-10767.
16. GORSHKOVA, I.I., RAUSCH, J.W., LE GRICE, S.F., and CROUCH, R.J. (2001). HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes. Anal. Biochem. 291, 198-206.
17. HELD, D.M., KISSEL, J.D., PATTERSON, J.T., NICKENS, D.G., and BURKE, D.H. (2006a). HIV-1 inactivation by nucleic acid aptamers. Front. Biosci. 11, 89-112.
18. HELD, D.M., KISSEL, J.D., SARAN, D., MICHALOWSKI, D., and BURKE, D.H. (2006b). Differential susceptibility of HIV-1 reverse transcriptase to inhibition by RNA aptamers in enzymatic reactions monitoring specific steps during genome replication. J. Biol. Chem. 281, 25712-25722.
19. HSIEH, J.C., ZINNEN, S., and MODRICH, P. (1993). Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268, 24607-24613.
20. HUANG, H., CHOPRA, R., VERDINE, G.L., and HARRISON, S.C. (1998). Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance [see comments]. Science 282, 1669-1675.
21. JAEGER, J., RESTLE, T., and STEITZ, T.A. (1998). The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. EMBO J. 17, 4535-4542.
22. JAMES, W. (2007). Aptamers in the virologists' toolkit. J. Gen. Virol. 88, 351-364.
23. JOSHI, P., and PRASAD, V.R. (2002). Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). J. Virol. 76, 6545-6557.
24. JOSHI, P.J., FISHER, T.S., and PRASAD, V.R. (2003). Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals. Curr. Drug Targets Infect. Disord. 3, 383-400.
25. JOSHI, P.J., NORTH, T.W., and PRASAD, V.R. (2005). Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol. Ther. 11, 677-686.
26. JOYCE, G.F. (1989). Amplification, mutation and selection of catalytic RNA. Gene 82, 83-87.
27. KENSCH, O., CONNOLLY, B.A., STEINHOFF, H.J., MCGREGOR, A., GOODY, R.S., and RESTLE, T. (2000). HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. J. Biol. Chem. 275, 18271-18278.
28. KISSEL, J.D., HELD, D.M., HARDY, R.W., and BURKE, D.H. (2007a). Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers. Nucleic Acids Res. 35, 5039-5050.
29. KISSEL, J.D., HELD, D.M., HARDY, R.W., and BURKE, D.H. (2007b). Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs. AIDS Res. Hum. Retroviruses 23, 699-708.
30. KOHLSTAEDT, L.A., WANG, J., FRIEDMAN, J.M., RICE, P.A., and STEITZ, T.A. (1992). Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790.
31. KOLB, G., REIGADAS, S., CASTANOTTO, D., FAURE, A., VENTURA, M., ROSSI, J.J., and TOULME, J.J. (2006). Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol. 3, 150-156.
32. LAVIGNE, C., YELLE, J., SAUVE, G., and THIERRY, A.G. (2001). Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication. AAPS PharmSci. 3, E7.
33. 15N labeling. Nucleic Acids Symp. Ser. (Oxf.) 69-70.
34. MATZEN, K., ELZAOUK, L., MATSKEVICH, A.A., NITZSCHE, A., HEINRICH, J., and MOELLING, K. (2007). RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides. Nat. Biotechnol. 25, 669-674.
35. METIFIOT, M., LEON, O., TARRAGO-LITVAK, L., LITVAK, S., and ANDREOLA, M.L. (2005). Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT. Biochimie 87, 911-919.
36. METIFIOT, M., FAURE, A., GUYONNET-DUPERAT, V., BELLECAVE, P., LITVAK, S., VENTURA, M., and ANDREOLA, M.L. (2007). Cellular uptake of ODNs in HIV-1 human-infected cells: a role for viral particles in DNA delivery? Oligonucleotides 17, 151-165.
37. MOELLING, K., ABELS, S., JENDIS, J., MATSKEVICH, A., and HEINRICH, J. (2006). Silencing of HIV by hairpin-loop-structured DNA oligonucleotide. FEBS Lett. 580, 3545-3550.
38. MOSING, R.K., MENDONSA, S.D., and BOWSER, M.T. (2005). Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal. Chem. 77, 6107-6112.
39. NAEGER, L.K., MARGOT, N.A., and MILLER, M.D. (2002). ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 46, 2179-2184.
40. NIMJEE, S.M., RUSCONI, C.P., and SULLENGER, B.A. (2005). Aptamers: an emerging class of therapeutics. Annu. Rev. Med. 56, 555-583.
41. PATEL, P.H., JACOBO-MOLINA, A., DING, J., TANTILLO, C., CLARK, A.D., JR., RAAG, R., NANNI, R.G., HUGHES, S.H., and ARNOLD, E. (1995). Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry 34, 5351-5363.
42. PELISKA, J.A., and BENKOVIC, S.J. (1992). Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258, 1112-1118.
43. PORSCHEWSKI, P., GRATTINGER, M.A., KLENZKE, K., ERPENBACH, A., BLIND, M.R., and SCHAFER, F. (2006). Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification. J. Biomol. Screen. 11, 773-781.
44. RAUSCH, J.W., and LE GRICE, S.F. (2004). 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int. J. Biochem. Cell Biol. 36, 1752-1766.
45. SAMBROOK, J. and RUSSELL, D.W. (2001). Molecular cloning: A Laboratory Manual, 3rd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp 1274-1280.
46. SCHNEIDER, D.J., FEIGON, J., HOSTOMSKY, Z., and GOLD, L. (1995). High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34, 9599-9610.
47. SLUIS-CREMER, N., ARION, D., PARIKH, U., KOONTZ, D., SCHINAZI, R.F., MELLORS, J.W., and PARNIAK, M.A. (2005). The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1. J. Biol. Chem. 280, 29047-29052.
48. SMITH, A.J., and SCOTT, W.A. (2006). The influence of natural substrates and inhibitors on the nucleotide-dependent excision activity of HIV-1 reverse transcriptase in the infected cell. Curr. Pharm. Des. 12, 1827-1841.
49. TONG, W., LU, C.-D., SHARMA, S.K., MATSUURA, S., SO, A.G., and SCOTT, W.A. (1997). Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase. Biochemistry 36, 5749-5757.
50. TRIPATHI, S., CHAUBEY, B., BARTON, B.E., and PANDEY, V.N. (2007). Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome. Virology 363, 91-103.
51. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
52. TUERK, C., MACDOUGAL, S., and GOLD, L. (1992). RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 89, 6988-6992.
53. WÖHRL, B.M., and MOELLING, K. (1990). Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. Biochemistry 29, 10141-10147.
54. WÖHRL, B.M., TANTILLO, C., ARNOLD, E., and LE GRICE, S.F. (1995). An expanded model of replicating human immunodeficiency virus reverse transcriptase. Biochemistry 34, 5343-5356.
55. ZHANG, Z., BLANK, M., and SCHLUESENER, H.J. (2004). Nucleic acid aptamers in human viral disease. Arch. Immunol. Ther. Exp. (Warsz). 52, 307-315.
56. ZUKER, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.